• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首届连续性肾脏替代治疗国际共识会议。

The first international consensus conference on continuous renal replacement therapy.

作者信息

Kellum John A, Mehta Ravindra L, Angus Derek C, Palevsky Paul, Ronco Claudio

机构信息

Department of Critical Care Medicine and Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

出版信息

Kidney Int. 2002 Nov;62(5):1855-63. doi: 10.1046/j.1523-1755.2002.00613.x.

DOI:10.1046/j.1523-1755.2002.00613.x
PMID:12371989
Abstract

BACKGROUND

Management of acute renal failure (ARF) in the critically ill is extremely variable and there are no published standards for the provision of renal replacement therapy in this population. We sought to review the available evidence, make evidence-based practice recommendations, and delineate key questions for future study.

METHODS

We undertook an evidence-based review of the literature on continuous renal replacement therapy (CRRT) using MEDLINE searches. We determined a list of key questions and convened a 2-day consensus conference to develop summary statements via a series of alternating breakout and plenary sessions. In these sessions, we identified supporting evidence and generated practice guidelines and/or directions for future research.

RESULTS

Of the 46 questions considered, we found consensus for 20. We found inadequate evidence for 21 questions and for the remaining five we found data but no consensus. Full versions of workgroup findings are available on the Internet at http://www.ADQI.net.

CONCLUSIONS

Despite limited data, broad areas of consensus exist for use of CRRT and guideline development appears feasible. Equally broad areas of disagreement also exist and additional basic and applied research in acute renal failure is needed.

摘要

背景

危重症患者急性肾衰竭(ARF)的管理差异极大,且目前尚无针对该人群提供肾脏替代治疗的公开标准。我们旨在回顾现有证据,提出基于证据的实践建议,并明确未来研究的关键问题。

方法

我们通过MEDLINE检索对连续性肾脏替代治疗(CRRT)的文献进行了循证综述。我们确定了一系列关键问题,并召开了为期2天的共识会议,通过一系列交替进行的分组讨论和全体会议来制定总结声明。在这些会议中,我们确定了支持证据,并生成了实践指南和/或未来研究方向。

结果

在审议的46个问题中,我们对其中20个达成了共识。对于21个问题,我们发现证据不足;对于其余5个问题,我们找到了相关数据,但未达成共识。工作组研究结果的完整版本可在互联网上查阅,网址为http://www.ADQI.net。

结论

尽管数据有限,但在CRRT的使用方面存在广泛的共识领域,指南制定似乎是可行的。同样也存在广泛的分歧领域,因此需要对急性肾衰竭进行更多的基础研究和应用研究。

相似文献

1
The first international consensus conference on continuous renal replacement therapy.首届连续性肾脏替代治疗国际共识会议。
Kidney Int. 2002 Nov;62(5):1855-63. doi: 10.1046/j.1523-1755.2002.00613.x.
2
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.急性肾衰竭——定义、预后指标、动物模型、液体治疗及信息技术需求:急性透析质量倡议(ADQI)小组第二次国际共识会议
Crit Care. 2004 Aug;8(4):R204-12. doi: 10.1186/cc2872. Epub 2004 May 24.
3
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.肝肾综合征:急性透析质量倡议 (ADQI) 第 8 次国际共识会议专家组报告。
Crit Care. 2012 Feb 9;16(1):R23. doi: 10.1186/cc11188.
4
Fluid and volume monitoring.液体与容量监测
Int J Artif Organs. 2008 Feb;31(2):111-26. doi: 10.1177/039139880803100205.
5
Nomenclature for renal replacement therapy in acute kidney injury: basic principles.急性肾损伤中肾脏替代治疗的命名:基本原则
Crit Care. 2016 Oct 10;20(1):318. doi: 10.1186/s13054-016-1489-9.
6
[Influence of time of initiation of continuous renal replacement therapy on prognosis of critically ill patients with acute kidney injury].[持续肾脏替代治疗起始时间对急性肾损伤危重症患者预后的影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Jul;25(7):415-9. doi: 10.3760/cma.j.issn.2095-4352.2013.07.012.
7
[Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies].[接受持续肾脏替代治疗的急性肾衰竭患者耐甲氧西林金黄色葡萄球菌感染治疗中的抗生素剂量调整]
Enferm Infecc Microbiol Clin. 2012 May;30(5):249-56. doi: 10.1016/j.eimc.2011.09.013. Epub 2011 Nov 29.
8
The Acute Dialysis Quality Initiative II: the Vicenza conference.急性透析质量倡议II:维琴察会议
Adv Ren Replace Ther. 2002 Oct;9(4):290-3. doi: 10.1053/jarr.2002.35574.
9
Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference.急性肾替代治疗的护理质量和安全措施:第 22 届急性疾病质量倡议 (ADQI) 共识会议工作组声明。
J Crit Care. 2019 Dec;54:52-57. doi: 10.1016/j.jcrc.2019.07.003. Epub 2019 Jul 5.
10
The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.国际复苏联合委员会(ILCOR)关于儿科和新生儿患者的科学共识及治疗建议:儿科基础与高级生命支持
Pediatrics. 2006 May;117(5):e955-77. doi: 10.1542/peds.2006-0206. Epub 2006 Apr 17.

引用本文的文献

1
Levetiracetam dosing in continuous renal replacement therapy: A systematic review and development of a novel pharmacokinetic model to optimise dosing in critically ill patients. Do recommended doses achieve therapeutic drug concentrations?左乙拉西坦在持续肾脏替代治疗中的给药:一项系统评价及一种新型药代动力学模型的建立以优化危重症患者的给药。推荐剂量能达到治疗药物浓度吗?
J Intensive Care Soc. 2025 Feb 24;26(2):193-204. doi: 10.1177/17511437251320557. eCollection 2025 May.
2
A hypothesis on treatment strategy of severe multicentric Castleman disease with continuous renal replacement therapy.关于连续性肾脏替代治疗重症多中心 Castleman 病的治疗策略假说。
J Cell Mol Med. 2024 Sep;28(17):e70026. doi: 10.1111/jcmm.70026.
3
Data-driven prediction of continuous renal replacement therapy survival.
基于数据驱动的连续肾脏替代治疗存活率预测。
Nat Commun. 2024 Jun 27;15(1):5440. doi: 10.1038/s41467-024-49763-3.
4
Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry.聚季铵盐-24 纤维固定化柱对内毒素清除治疗:EUPHAS2 注册研究的单中心经验。
Sci Rep. 2023 Oct 16;13(1):17600. doi: 10.1038/s41598-023-44850-9.
5
Antithrombin Therapy: Current State and Future Outlook.抗凝血酶治疗:现状与未来展望。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231205279. doi: 10.1177/10760296231205279.
6
In vivo imaging of renal microvasculature in a murine ischemia-reperfusion injury model using optical coherence tomography angiography.利用光相干断层扫描血管造影术在小鼠缺血再灌注损伤模型中对肾脏微血管进行体内成像。
Sci Rep. 2023 Apr 19;13(1):6396. doi: 10.1038/s41598-023-33295-9.
7
Acute kidney injury.急性肾损伤
Intensive Care Med. 2023 Feb;49(2):219-222. doi: 10.1007/s00134-022-06946-0. Epub 2023 Jan 2.
8
Survival and recovery modeling of acute kidney injury in critically ill adults.危重症成年患者急性肾损伤的生存与恢复模型
SAGE Open Med. 2022 May 26;10:20503121221099359. doi: 10.1177/20503121221099359. eCollection 2022.
9
The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.危重症患者持续肾脏替代治疗时,柠檬酸盐对心血管系统和凝血回路的影响。
J Artif Organs. 2023 Mar;26(1):53-64. doi: 10.1007/s10047-022-01329-0. Epub 2022 Apr 12.
10
Does hemofiltration protect the brain after head trauma? An experimental study in rabbits.血液滤过对颅脑创伤后大脑有保护作用吗?一项在兔子身上的实验研究。
Intensive Care Med Exp. 2020 Nov 18;8(1):66. doi: 10.1186/s40635-020-00357-5.